Organic Letters
Letter
activated through the quinuclidine amine function and the N-
hetaryl substituents on a C-9 ester, and the Michael acceptor was
associated with the quinoline phenol through a developing
hydrogen bond. The enantioselective nucleophilic addition
takes place via a concerted hydrogen transfer. Then the chiral
base captures another proton of the hydrozylamine to give
oxygen anion III. After nucleophilic attack of the oxygen anion to
the allenyl ketone intermediate III, transition state IV forms and
subsequent protonation affords product 4.
In summary, we have developed a facile asymmetric formal
cycloaddition of electron-deficient 1,3-enynes and N-hydroxyl-
amines. The newly designed organocatalysts derived from
cinchona alkaloids were demonstrated as optimal catalytic
systems for inducing asymmetry in the synthesis of highly
substituted 2,3-dihydroisoxazoles in high yields (up to 90%) with
excellent enantioselectivities (ee up to 99%). Further develop-
ment of a novel asymmetric organocatalytic system is ongoing in
our laboratory.
(6) Cai, X.; Wang, C.; Sun, J. Adv. Synth. Catal. 2012, 354, 359.
7) Aleman, J.; Fraile, A.; Marzo, L.; Ruano, J. L. G.; Izquierdo, C.;
Díaz-Tendero, S. Adv. Synth. Catal. 2012, 354, 1665.
(8) For selected reviews on asymmetric organocatalysis with cinchona
and their derivatives, see: (a) Tian, S.-K.; Chen, Y.; Hang, J.; Tang, L.;
McDaid, P.; Deng, L. Acc. Chem. Res. 2004, 37, 621. (b) Hoffmann, H.
M. R.; Frackenpohl, J. Eur. J. Org. Chem. 2004, 2004, 4293. (c) Chen, Y.-
C. Synlett 2008, 2008, 1919. (d) Marcelli, T.; Hiemstra, H. Synthesis
(
́
1
6
2
010, 2010, 1229.
(9) (a) Li, H.; Wang, Y.; Tang, L.; Deng, L. J. Am. Chem. Soc. 2004, 126,
9906. (b) Li, H.; Wang, Y.; Tang, L.; Deng, L. Angew. Chem., Int. Ed.
2005, 44, 105. (c) Li, H.; Wang, B.; Deng, L. J. Am. Chem. Soc. 2006, 128,
7
4
32. (d) Wu, F.; Li, H.; Hong, R.; Deng, L. Angew. Chem., Int. Ed. 2006,
5, 947. (e) Wu, F.; Hong, R.; Khan, J.; Liu, X.; Deng, L. Angew. Chem.,
Int. Ed. 2006, 45, 4301.
10) For selected examples of 6′-OH cinchona alkaloids as bifunctional
catalysts, see: (a) Wang, J.; Li, H.; Zu, L.; Wang, W. Org. Lett. 2006, 8,
391. (b) Wang, Y.; Li, H.; Wang, Y.-Q.; Liu, Y.; Foxman, B. M.; Deng,
(
1
L. J. Am. Chem. Soc. 2007, 129, 6364. (c) Bandini, M.; Sinisi, R.; Umani-
Ronchi, A. Chem. Commun. 2008, 4360. (d) Wang, H.-F.; Cui, H.-F.;
Chai, Z.; Li, P.; Zheng, C.-W.; Yang, Y.-Q.; Zhao, G. Chem. - Eur. J. 2009,
15, 13299. (e) Liu, Y.; Sun, B.; Wang, B.; Wakem, M.; Deng, L. J. Am.
Chem. Soc. 2009, 131, 418. (f) Chauhan, P.; Chimni, S. S. Eur. J. Org.
Chem. 2011, 2011, 1636. (g) Metro, T.-X.; Cochi, A.; Pardo, D. G.;
́
Cossy, J. J. Org. Chem. 2011, 76, 2594. (h) Chauhan, P.; Chimni, S. S.
RSC Adv. 2012, 2, 737.
ASSOCIATED CONTENT
Supporting Information
■
*
S
(
11) For selected examples, see: (a) Li, H.; Song, J.; Liu, X.; Deng, L. J.
Descriptions of experimental procedures for compounds
and analytical characterization(PDF)
X-ray data for compound 4ag (CIF)
Am. Chem. Soc. 2005, 127, 8948. (b) Wang, J.; Li, H.; Zu, L.; Jiang, W.;
Wang, W. Adv. Synth. Catal. 2006, 348, 2047. (c) Dodda, R.; Goldman, J.
J.; Mandal, T.; Zhao, C. G.; Broker, G. A.; Tiekink, E. R. T. Adv. Synth.
Catal. 2008, 350, 537. (d) Lu, J.; Zhou, W.; Liu, F.; Loh, T. Adv. Synth.
Catal. 2008, 350, 1796. (e) Li, H.; Zhang, S.; Yu, C.; Song, X.; Wang, W.
Chem. Commun. 2009, 2136. (f) Xuan, Y.; Nie, S.; Dong, L.; Zhang, J.;
Yan, M. Org. Lett. 2009, 11, 1583. (g) Raimondi, W.; Lettieri, G.;
Dulcere, J. P.; Bonne, D.; Rodriguez, J. Chem. Commun. 2010, 46, 7247.
(h) Chauhan, P.; Chimni, S. S. Adv. Synth. Catal. 2011, 353, 3203.
AUTHOR INFORMATION
■
*
Notes
(
(
(
i) He, P.; Liu, X.; Shi, J.; Lin, L.; Feng, X. Org. Lett. 2011, 13, 936.
j) Buyck, T.; Wang, Q.; Zhu, J. Angew. Chem., Int. Ed. 2013, 52, 12714.
k) Zhao, Y.; Wang, X.-J.; Lin, Y.; Cai, C.-X.; Liu, J.-T. Tetrahedron 2014,
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
70, 2523. (l) Cabanillas, A.; Davies, C. D.; Male, L.; Simpkins, N. S.
Chem. Sci. 2015, 6, 1350.
We are grateful for financial support from the National Natural
Science Foundation of China (21425205, 21372084), the
Shanghai Eastern Scholar Program, and the Shanghai Sailing
Program (16YF1402800).
(12) (a) Yu, X.; Du, B.; Wang, K.; Zhang, J. Org. Lett. 2010, 12, 1876.
(b) Xiao, Y.; Yu, Y.; Zhang, J. Angew. Chem., Int. Ed. 2008, 47, 1903.
(
(
c) Liu, F.; Yu, Y.; Zhang, J. Angew. Chem., Int. Ed. 2009, 48, 5505.
d) Liu, F.; Qian, D.; Li, L.; Zhao, X.; Zhang, J. Angew. Chem., Int. Ed.
2
010, 49, 6669. (e) Zhang, Z.-M.; Chen, P.; Li, W.; Niu, Y.; Zhao, X.;
REFERENCES
■
Zhang, J. Angew. Chem., Int. Ed. 2014, 53, 4350. (f) Zhou, L.; Zhang, M.;
Li, W.; Zhang, J. Angew. Chem., Int. Ed. 2014, 53, 6542. (g) Wang, Y.;
Zhang, P.; Qian, D.; Zhang, J. Angew. Chem., Int. Ed. 2015, 54, 14849.
(
1) For reviews of 2,3-dihydroisoxazoles, see: (a) Freeman, J. P. Chem.
Rev. 1983, 83, 241. (b) Gru
Chemistry of Heterocyclic Compounds; Taylor, E. C., Weissberger, A., Ed.;
John Wiley & Sons, 1991; Chapter 2, pp 416−647. (c) Pinho e Melo, T.
M. V. D. Eur. J. Org. Chem. 2010, 2010, 3363.
̈
nanger, P.; Vita-Finzi, P. Isoxazolines. In The
(
13) Catalyst 3i was reported as a ligand in an asymmetric
cycloaddition reaction; see: Wang, L.; Yang, D.; Han, F.; Li, D.; Zhao,
D.; Wang, R. Org. Lett. 2015, 17, 176.
(
2) (a) Atienza, J. M.; Susanto, D.; Huang, C.; McCarty, A. S.; Colicelli,
(
14) A similar catalyst was reported as an effective catalyst for
asymmetric aldol reaction; see: Zheng, Y.; Deng, L. Chem. Sci. 2015, 6,
510.
15) CCDC 1495440 (4ag) contains the supplementary crystallo-
graphic data for this compound.
16) (a) Wang, B.; Wu, F.; Wang, Y.; Liu, X.; Deng, L. J. Am. Chem. Soc.
007, 129, 768. (b) Li, H.; Song, J.; Deng, L. Tetrahedron 2009, 65, 3139.
c) Deng, Y.; Zhang, Z.; Feng, Y.; Chan, A. S. C.; Lu, G. Tetrahedron:
Asymmetry 2012, 23, 1647.
J. J. Biol. Chem. 1999, 274, 4839. (b) Habeeb, A. G.; Praveen Rao, P. N.;
Knaus, E. E. J. Med. Chem. 2001, 44, 2921. (c) Cramer, R. D.; Jilek, R. J.;
Guessregen, S.; Clark, S. J.; Wendt, B.; Clark, R. D. J. Med. Chem. 2004,
6
(
4
7, 6777. (d) Hubich, A. I.; Zheldakova, T. A.; Chernikhova, T. V.;
Koroleva, E. V.; Lakhvich, F. A.; Sholukh, M. V. Biochem. Biophys. Res.
Commun. 2006, 341, 357. (e) Fraley, M. E.; Garbaccio, R. M.; Hartman,
G. D. PCT Int. Appl. WO2006/023440, 2006.
(
2
(
(
3) (a) Bruche,
Viani, F. Eur. J. Org. Chem. 1999, 1999, 1665. (b) Busque,
P.; Figueredo, M.; Font, J.; Gallagher, T.; Milan, S. Tetrahedron:
Asymmetry 2002, 13, 437. (c) Francois, D.; Maden, A.; Murray, W. V.
́
L.; Arnone, A.; Bravo, P.; Panzeri, W.; Pesenti, C.;
́
F.; de March,
́
̧
Org. Lett. 2004, 6, 1931. (d) Cantagrel, F.; Pinet, S.; Gimbert, Y.;
Chavant, P. Y. Eur. J. Org. Chem. 2005, 2005, 2694.
(
7
(
2
4) Ukaji, Y.; Inomata, K.; Wei, W.; Kobayashi, M. Heterocycles 2009,
8, 717.
5) Sakakura, A.; Hori, M.; Fushimi, M.; Ishihara, K. J. Am. Chem. Soc.
010, 132, 15550.
D
Org. Lett. XXXX, XXX, XXX−XXX